Literature DB >> 19571233

An imbalance of esophageal effector and regulatory T cell subsets in experimental eosinophilic esophagitis in mice.

Xiang Zhu1, Meiqin Wang, Caleb H Crump, Anil Mishra.   

Abstract

We recently reported a critical role for T cells in the induction of eosinophilic esophagitis (EE) in mice; however, the role of specific T cell subsets in disease pathogenesis is not yet understood. In the current study, we tested the hypothesis that allergen-induced EE develops in response to the disproportion of functionally different effector and regulatory T cells in the esophagus. Fluorescence-activated cell sorter analysis was performed to examine activated T cell subsets using the cell surface activation markers CD25 and CD69. A significant increase in activated CD4(+) and CD4(-) T cells was observed in the total esophageal cells isolated from the mouse model of EE. Furthermore, an imbalance in the effector and regulatory T cells was observed in the esophagus. The esophageal CD4(+)CD45RB(high) effector T cells in allergen-challenged mice increased compared with saline-challenged mice (65.4 +/- 3.6 x 10(3) to 44.8 +/- 4.2 x 10(3)), whereas CD4(+)CD45RB(low) mostly regulatory T cells decreased in allergen-challenged mice compared with saline-challenged mice (5.8 +/- 0.9 x 10(3) from 10.2 +/- 1.7 x 10(3)). The functional characteristics were examined by analysis of the pro- and anti-inflammatory cytokine profile of purified low and high CD4(+)CD45RB subsets from the spleen. Additionally, a significantly reduced interleukin (IL)-2 production by CD4(+)CD45RB(low) cells in allergen-challenged mice compared with saline-challenged mice was observed. The reduced IL-2 in the CD4(+)CD45RB(low) subset may be associated with reduction of CD4(+)CD45RB(low) subset. In conclusion, our results suggest that local regulatory interaction of CD45RB(high) and CD45RB(low) CD4(+) T cells may be required for protective and pathogenic immunity in EE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19571233      PMCID: PMC2739823          DOI: 10.1152/ajpgi.00148.2009

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  41 in total

Review 1.  Regulatory T cells in the control of immune pathology.

Authors:  K J Maloy; F Powrie
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

2.  Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen.

Authors:  K M Thorstenson; A Khoruts
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

3.  Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy.

Authors:  Andre van van Maurik; Manuela Herber; Kathryn J Wood; Nick D Jones
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

4.  Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions.

Authors:  Z Liu; K Geboes; S Colpaert; L Overbergh; C Mathieu; H Heremans; M de Boer; L Boon; G D'Haens; P Rutgeerts; J L Ceuppens
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

Review 5.  Regulatory T cells and intestinal homeostasis.

Authors:  Janine L Coombes; Nicholas J Robinson; Kevin J Maloy; Holm H Uhlig; Fiona Powrie
Journal:  Immunol Rev       Date:  2005-04       Impact factor: 12.988

Review 6.  Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance.

Authors:  S Sakaguchi; N Sakaguchi; J Shimizu; S Yamazaki; T Sakihama; M Itoh; Y Kuniyasu; T Nomura; M Toda; T Takahashi
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

7.  Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration.

Authors:  X Zhang; L Izikson; L Liu; H L Weiner
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

8.  An etiological role for aeroallergens and eosinophils in experimental esophagitis.

Authors:  A Mishra; S P Hogan; E B Brandt; M E Rothenberg
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

9.  Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells.

Authors:  Claudia Zuany-Amorim; Elzbieta Sawicka; Corinne Manlius; Alain Le Moine; Laura R Brunet; David M Kemeny; Gareth Bowen; Graham Rook; Christoph Walker
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

10.  IL-5 promotes eosinophil trafficking to the esophagus.

Authors:  Anil Mishra; Simon P Hogan; Eric B Brandt; Marc E Rothenberg
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

View more
  15 in total

1.  Antigen presentation and MHC class II expression by human esophageal epithelial cells: role in eosinophilic esophagitis.

Authors:  Daniel J Mulder; Aman Pooni; Nanette Mak; David J Hurlbut; Sameh Basta; Christopher J Justinich
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 2.  Eosinophilic esophagitis: allergic contribution, testing, and management.

Authors:  Amindra A Arora; Catherine R Weiler; David A Katzka
Journal:  Curr Gastroenterol Rep       Date:  2012-06

3.  Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice.

Authors:  Xiang Zhu; Meiqin Wang; Parm Mavi; Madhavi Rayapudi; Akhilesh K Pandey; Ajay Kaul; Philip E Putnam; Marc E Rothenberg; Anil Mishra
Journal:  Gastroenterology       Date:  2010-04-08       Impact factor: 22.682

4.  Significance of para-esophageal lymph nodes in food or aeroallergen-induced iNKT cell-mediated experimental eosinophilic esophagitis.

Authors:  Priya Rajavelu; Madhavi Rayapudi; Matthew Moffitt; Akanksha Mishra; Anil Mishra
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-29       Impact factor: 4.052

Review 5.  Novel immunologic mechanisms in eosinophilic esophagitis.

Authors:  Julie M Caldwell; Misu Paul; Marc E Rothenberg
Journal:  Curr Opin Immunol       Date:  2017-09-29       Impact factor: 7.486

6.  Common variants at 5q22 associate with pediatric eosinophilic esophagitis.

Authors:  Marc E Rothenberg; Jonathan M Spergel; Joseph D Sherrill; Kiran Annaiah; Lisa J Martin; Antonella Cianferoni; Laura Gober; Cecilia Kim; Joseph Glessner; Edward Frackelton; Kelly Thomas; Carine Blanchard; Chris Liacouras; Ritu Verma; Seema Aceves; Margaret H Collins; Terri Brown-Whitehorn; Phil E Putnam; James P Franciosi; Rosetta M Chiavacci; Struan F A Grant; J Pablo Abonia; Patrick M A Sleiman; Hakon Hakonarson
Journal:  Nat Genet       Date:  2010-03-07       Impact factor: 38.330

7.  TGF-β1: Mediator of a feedback loop in eosinophilic esophagitis--or should we really say mastocytic esophagitis?

Authors:  J Pablo Abonia; James P Franciosi; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2010-12       Impact factor: 10.793

Review 8.  The link between allergies and eosinophilic esophagitis: implications for management strategies.

Authors:  Terri F Brown-Whitehorn; Jonathan M Spergel
Journal:  Expert Rev Clin Immunol       Date:  2010-01       Impact factor: 4.473

Review 9.  Allergic mechanisms in eosinophilic esophagitis.

Authors:  Joshua B Wechsler; Paul J Bryce
Journal:  Gastroenterol Clin North Am       Date:  2014-03-22       Impact factor: 3.806

10.  High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders.

Authors:  J Pablo Abonia; Ting Wen; Emily M Stucke; Tommie Grotjan; Molly S Griffith; Katherine A Kemme; Margaret H Collins; Philip E Putnam; James P Franciosi; Karl F von Tiehl; Brad T Tinkle; Keith A Marsolo; Lisa J Martin; Stephanie M Ware; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2013-04-19       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.